logo_centered_440x386.png
PacBio Grants Equity Incentive Award to New Employee
27 juin 2022 20h00 HE | PacBio
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
logo_centered_440x386.png
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
08 mai 2022 19h00 HE | PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
logo_centered_440x386.png
パックバイオ (PacBio)、iLACおよびロボティック・バイオロジー・インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
08 mai 2022 19h00 HE | Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質・高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック・バイオロジー・インスティテュート株式会社 (Robotic...
logo_centered_440x386.png
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
05 mai 2022 16h10 HE | PacBio
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s...
logo_centered_440x386.png
PacBio Announces First Quarter 2022 Financial Results
04 mai 2022 16h03 HE | PacBio
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a...
logo_centered_440x386.png
PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease
21 avr. 2022 09h10 HE | PacBio
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research...
logo_centered_440x386.png
PacBio transforms access to the epigenome and streamlines workflows
21 avr. 2022 09h00 HE | PacBio
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the release of a...
logo_centered_440x386.png
PacBio to Report First Quarter 2022 Financial Results on May 4, 2022
20 avr. 2022 16h02 HE | PacBio
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on...
logo_centered_440x386.png
PacBio Enters Agricultural Industry Collaboration with Corteva Agriscience to Develop High-Throughput Plant, Pest and Microbial Sequencing
04 avr. 2022 09h00 HE | PacBio
MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with...
Callout
HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology
31 mars 2022 14h00 HE | PacBio
MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, announced today PacBio’s essential...